Obicetrapib's potential regulatory filing by 2025 and its competitive edge over similar drugs ... non-statin options like PCSK9 inhibitors. These are also good options for controlling cholesterol ...
To prevent these problems, doctors often prescribe cholesterol-lowering drugs. Statins are the most commonly prescribed cholesterol-lowering medications, used by more than 200 million people ...
2 The use of statins has emerged as a risk factor for the onset of type 2 diabetes, 3,4 especially in individuals that are already at high risk for developing diabetes. Statins lead to upregulation of ...